Patients drop MS drug, face relapse risk
A study of discontinuing natalizumab for multiple sclerosis patients testing positive for JC virus antibody found a higher relapse rate within 6 months than for patients continuing the… read more.
A study of discontinuing natalizumab for multiple sclerosis patients testing positive for JC virus antibody found a higher relapse rate within 6 months than for patients continuing the… read more.
New guidelines on dyslipidemia and the prevention of atherogenesis give official sanction to something endocrinologists have been doing for years: lowering LDL targets.
Latest study says regular follow-up positive. Scientist say there is an urgent need for research into all aspects of follow-up care in lung cancer. The study presented in… read more.
Like special-forces troops laser-tagging targets for a bomber pilot, tiny particles that can be imaged three different ways at once have enabled Stanford University School of Medicine scientists… read more.
by Dr Sunil Upadhyay – Basal cell carcinoma is the most common malignancy in the world. Its incidence is common in people with fair skin due to excessive… read more.
by Dr Sunil Upadhyay – One of the most important advances in cancer research over the last decade or so has been the appearance of targeted therapies. It… read more.
by Dr Sunil Upadhyay – It would be difficult to imagine how one would treat breast cancer today if it was not for the work and leadership of… read more.
by Professor John Dark (pictured) – In contrast with that other thoracic organ the heart, activity and optimism in the pulmonary field are both increasing. Contemporay outcomes for… read more.
FDA Highlights – by Bruce Sylvester – Patients who received standard therapy for cystic fibrosis plus adjunctive inhaled dry powder mannitol have achieved sustained improvement in lung function… read more.
Researchers from the University of Southampton, in collaboration with psychologists from six other universities, have started a study to assess the impact of a new psychological therapy for… read more.
Brief adherence programmes improve diabetes test results and depression symptoms. Patients simultaneously treated for both Type 2 diabetes and depression showed improved medication compliance and significantly improved blood… read more.
by Dr. Riyaz Shah, Consultant Medical Oncologist, Kent Oncology Centre – The ASCO 2011 Annual Meeting took place in early June at the vast McCormick Place Convention Centre… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.